Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-08-28
The reference study identifies circulating moesin as a candidate indicator of endothelial injury and sepsis severity, linking serum measurements with SOFA scores, procalcitonin, lung permeability, and tissue injury. Its combination of patient data, LPS and CLP mouse models, and moesin-silenced endothelial cells also suggests that the Rock1/MLC and NF-κB pathways connect moesin to inflammatory barrier dysfunction.
-
WM-8014 and the Logic of KAT6A-Driven Senescence
2026-08-27
WM-8014 provides a reversible chemical framework for testing how KAT6A/B-dependent acetylation controls proliferation, senescence, and oncogenic liver overgrowth. This thought-leadership perspective connects its mechanism to RESTRICT-seq, assay strategy, and translational decision-making.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-27
Brefeldin A is more than a vesicle transport inhibitor: it is a controlled perturbation of ER–Golgi trafficking that can expose how protein quality control shapes cellular stress and death. This guide connects BFA assay design with UBR1/UBR2 biology and provides practical, evidence-aware workflows for secretion, ER stress, and cancer-cell studies.
-
Moesin as a Sepsis Endothelial Injury Biomarker
2026-08-26
The 2021 study identifies circulating moesin as a candidate biomarker of endothelial injury and sepsis severity, linking patient observations with mouse and endothelial-cell experiments. Its central contribution is the association of moesin with Rock1/myosin light chain and NF-κB signaling, vascular leak, and inflammatory activation.
-
CHIR-99021 Workflow for Neuroimmune Stem Cell Assays
2026-08-26
CHIR-99021 (CT99021) gives researchers a controllable way to activate GSK-3-dependent Wnt signaling while building stem-cell, neuronal, and disease-model assays. This guide separates established product use from exploratory neuroimmune applications inspired by an M1-macrophage exosome study, with practical setup, controls, and troubleshooting guidance.
-
Intraarticular RTX for Osteoarthritic Pain
2026-08-25
The 2025 review positions intra-articular Resiniferatoxin (RTX) as a locally acting TRPV1-directed strategy for osteoarthritic pain, integrating mechanistic, animal, canine, and early human evidence. Its practical contribution is to connect analgesic durability with route, dose, volume, and patient-selection considerations while distinguishing promising signals from established clinical efficacy.
-
EPZ-6438 in Time-Resolved EZH2 Assays
2026-08-25
Explore how EPZ-6438, a selective EZH2 inhibitor, can clarify the timing-dependent relationship between PRC2 chromatin control, ERK–AKT signaling, and drug resistance. This practical framework translates recent melanoma findings into more rigorous epigenetic cancer research workflows.
-
Alcian Blue & Nuclear Fast Red Kit pH2.5
2026-08-24
The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 provides blue detection of acidic mucins and mucopolysaccharides with red nuclear counterstaining. Its chemistry supports chondrogenic differentiation staining and mucin-focused histology, but it should not be treated as a standalone diagnostic or quantitative assay.
-
From Annexin-V Biology to Translational Capture
2026-08-24
Early phosphatidylserine exposure can reveal cell death before DNA fragmentation becomes measurable, as demonstrated in a murine ischemia–reperfusion model using labeled annexin-V. This article examines how that mechanistic insight can inform ex vivo molecular-capture strategies, assay validation, and translational study design. It positions Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) as a flexible platform for isolating biotinylated proteins, nucleic acids, and assay components while emphasizing appropriate controls, sample compatibility, and the distinction between product capability and direct literature validation.
-
Biotin-16-UTP for RNA-Protein Mechanism Mapping
2026-08-23
Biotin-16-UTP enables selective biotin-labeled uridine triphosphate incorporation for RNA detection, purification, and RNA-protein interaction studies. This guide connects reagent design to the LINC02870–EIF4G1–SNAIL mechanism while defining practical controls and assay limitations.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-08-22
DiscoveryProbe Stem Cell Compound Library Plus supports mechanism-guided stem cell pathway profiling, differentiation studies, and high-content screening. This article explains how to convert its pathway breadth into interpretable, orthogonal assay decisions rather than relying on morphology alone.
-
Candida krusei Apoptosis in Bovine Mammary Cells
2026-08-21
The reference study shows that the yeast and hypha phases of Candida krusei both trigger apoptosis in bovine mammary epithelial cells, but through different dominant signaling routes. Its phase-resolved co-culture design links yeast-associated injury to mitochondrial dysfunction and hypha-associated injury to death ligand/receptor signaling, providing a useful framework for mechanistic apoptosis assays in fungal mastitis research.
-
AG-126 for ERK Signaling Assays and Neurobiology
2026-08-20
AG-126 provides a practical way to test whether ERK1/2 activity contributes to stimulus-responsive signaling, cytokine release, or neuronal phenotypes. This workflow connects established inflammatory-model evidence with a carefully bounded neurobiology application inspired by Neuroligin 1 and D2-MSN research.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-08-20
Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical pharmacologic approach for hypoxia-inducible factor stabilization under normoxic cell-culture conditions and for selected inflammation models. It is a research reagent only; the available dossier does not establish diagnostic, therapeutic, or clinical use, and no directly matched paper evidence is available for this product entry.
-
Brefeldin A Workflows for ER Stress and Cancer
2026-08-19
Brefeldin A converts disrupted ER-to-Golgi trafficking into a controllable experimental stress, making BFA useful for secretion studies, ER quality-control assays, and cancer phenotyping. This guide combines practical dosing, time-course design, apoptosis and migration readouts, and troubleshooting for more interpretable results.